BRAND_ANALYSIS#MODERNAHEALTH & PHARMA#10 OF 26 IN HEALTH & PHARMAINTERESTING
Moderna
· Public · Updated 11 Oct 2026 07:33 UTC
#286 of 1208 overall by tension · #10 of 26 in Health & Pharma
17Interesting
The Silent Giant
Analysis
Moderna is the outlier of this batch, with a 64.69% gain over 30 days at #286 driven by business momentum rather than culture, which sits at 50 against 67 on business. The tension of 17 is calm for a company whose stock has moved this violently. Speculation is doing the work here, and the market may be sprinting ahead of the story.
IN THE NEWS (100 articles this week)
Moderna stock hits 4-year high on planned national cancer vaccine effort - Yahoo Finance
Tempus Announces Multi-Year Collaboration with Moderna and Merck - Business Wire
Stocks making the biggest moves midday: Marvell, Moderna, Lamb Weston, Constellation Energy & more - CNBC